Symposium

Case Closed? Diagnosing Idiopathic Hypersomnia Beyond the Usual Suspects

Launch Date
06/16/2026 at 07:00 pm EDT
Credit Amount
1.5
Credit Expires
06/16/2026
Location Name Hyatt Regency Baltimore Inner Harbor
Address 300 Light St.
City Baltimore
State MD

Faculty

Anne Marie Morse, DO, FAASM
Moderator
Director, Child Neurology
Director, Pediatric Sleep Medicine
Program Director, Child Neurology Residency, Geisinger Janet Weis Children's Hospital
Associate Professor, Geisinger Commonwealth School of Medicine
Scranton, PA
Maggie Lavender, APRN, MSN, FNP-C
SMAPP Foundation President/Founder
Comprehensive Sleep Medicine Associates
The Woodlands, TX
David. T. Plante, MD, PhD
Associate Professor, Department of Psychiatry
Medical Director, Wisconsin Institute for Sleep and Consciousness
University of Wisconsin-Madison
Madison, WI
Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credit

Statement of Need

Idiopathic hypersomnia (IH) is a life-disrupting condition characterized by excessive daytime sleepiness (EDS) that makes waking up a daily struggle, limits productivity, and erodes overall quality of life. For many patients with IH, the journey to diagnosis is long and frustrating atop the disease burden itself. Overlapping symptoms with conditions such as depression, anxiety, and cardiovascular disease often obscure the true cause, while distinguishing IH itself from narcoleptic sleep disorders can be equally complex. As a rare condition, IH can leave patients feeling isolated and misunderstood while enduring an unpredictable constellation of symptoms. By sharpening diagnostic precision and fostering collaboration across multidisciplinary teams, clinicians can unlock new opportunities in the therapeutic landscape to deliver personalized, patient-centered care that addresses the unique challenges of living with IH.

This fast-paced and highly interactive live CaseWise™ symposium from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will compare their treatment choices to those of leading experts, peers in the room, providers in the community, patients themselves, and even AI-based insights. Learners will see how evidence translates into practice, what doesn’t, and why. Designed to challenge assumptions and sharpen strategy, this immersive format empowers clinicians to immediately apply guideline-recommended diagnostic criteria and comprehensive assessments into practice when there is clinical suspicion of IH to improve early and accurate diagnosis.

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Identify the nature of overlapping symptoms of IH and other hypersomnolence disorders
  • Integrate appropriate guideline-recommended diagnostic criteria and comprehensive assessments into practice when there is clinical suspicion of IH to improve early and accurate diagnosis
  • Evaluate the latest efficacy and safety data for current and emerging therapies for patients with IH

Financial Support

Supported by an educational grant from Alkermes.

Target Audience

Neurologists, psychiatrists, pulmonologists, primary care physicians (PCPs), nurse practitioners (NPs), and physician associates (PAs) with a focus on sleep medicine

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians (ACCME) 1.5

CME Outfitters, LLC, designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 1.5

This activity is designated for 1.50 contact hours.

California Residents: Provider approved by the California Board of Registered Nursing, Provider # CEP 15510, for 1.50 Contact Hours.

Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.

Physician Assistants (AAPA): 1.5

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC 1.5

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Morse reports the following financial relationships:

Advisory Board: Alkermes; Apnimed; Avadel Pharmaceuticals; Floraworks; NeuraHealth; and Pulse InfoFrame Inc

Consultant: Alkermes; Apnimed; Avadel; Harmony Biosciences; Lundbeck; Novartis; and Takeda Pharmaceuticals

Grants: Harmony Biosciences

Research Support: Alkermes; Avadel; Jazz Pharmaceuticals, Inc.; National Institutes of Health; Takeda Pharmaceuticals; and UCB

Speakers Bureau: Avadel; Harmony Biosciences; Lilly

Stock Shareholder (ownership interest): Floraworks (SAB), NanoMosaic (CAB)

Employment: DAMM Good Sleep, CEO

Other financial or material support: Forbes; Uptodate

Ms. Lavender reports no financial relationships to disclose.

Dr. Plante reports the following financial relationships:

Advisory Board: Alkermes; Apnimed, Inc.; Centessa Pharmaceuticals; Harmony Biosciences; Jazz Pharmaceuticals, Inc.; and Takeda Pharmaceuticals

Consultant: Aditum Bio, LLC; Alkermes; Centessa Pharmaceuticals ; Harmony Biosciences ; Jazz Pharmaceuticals, Inc. ; Takeda Pharmaceuticals; and Teva Pharmaceuticals (Australia)

The following individuals have no financial relationships to disclose:

Thai Nguyen, MD, MHA (Peer Reviewer)
Jessica Giddens, DNP, APRN, FPMHNP-BC, RN-BC (Peer Reviewer)
Keshia Pitt, PhD (Planning Committee)
Felicia Oyedepo, MD (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

*All identified conflicts of interest have been mitigated.

Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, planners, and reviewers do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (0% pass rate required). This website supports all browsers except Internet Explorer for Mac.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

MM-163-061626-64

Case Closed? Diagnosing Idiopathic Hypersomnia Beyond the Usual Suspects
Event Date: 06/16/2026 at 07:00 pm EDT
Begin